title: How can we develop therapies for glioblastoma more efficiently? Randomized versus single-arm studies.
authors.affiliation: Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center,  Boston, MA, USA.|Harvard Medical School, Boston, MA, USA.
authors.forename: Patrick Y
authors.initials: PY
authors.lastname: Wen
authors.affiliation: Department of Neurosurgery, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
authors.forename: Tao
authors.initials: T
authors.lastname: Jiang
authors.affiliation: Department of Neurology, University of Virginia, Charlottesville, Virginia, USA.
authors.forename: David
authors.initials: D
authors.lastname: Schiff
mesh_terms: D000328:Adult; D001932:Brain Neoplasms; D003606:Dacarbazine; D005909:Glioblastoma; D006801:Humans
chemical_list: D003606:Dacarbazine